Abstract
With the help of a routine clinical case, we highlighted the difference between two of the best asthma guidelines available at the time regarding therapeutic suggestions for the so-called “third step” for school-age asthmatic children. We have analyzed the scientific evidence that each of the two guidelines brings to support their position. Finally, we have motivatedly solved the clinical scenario. However, the question of disagreement between two guidelines remains unresolved. This can lead to unjustified differences in the management of schoolchildren with persistent asthma.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 789-791 |
| Numero di pagine | 3 |
| Rivista | Allergologia et Immunopathologia |
| Volume | 48 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2020 |
Keywords
- Asthma guidelines
- Inhaled corticosteroid
- Leukotriene receptor antagonist
- Long-acting β2 agonist
- School-age children
Fingerprint
Entra nei temi di ricerca di 'Disagreement between guidelines regarding the third step of asthma drug therapy for school-age children'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver